New Frontiers in Cardiovascular Genetics Beyond GWAS
Organizer(s): Jennifer L. Hall and Stephen S. RichDate: January 13 - 18, 2013
Location: Granlibakken Tahoe, Tahoe City, CA, USA
This meeting will highlight the latest advances in the field and new approaches in genomics and genetics applied to cardiovascular disease and risk factors. Research in the areas of DNA and RNA sequencing and bioinformatics, as it relates to heart failure, sudden cardiac death and coronary artery disease, will be presented from the perspectives of academia and industry around the world. Challenges in the pursuit of translating genetic findings into diagnostic tests and therapies will be discussed by leading experts who have identified new strategies. The sessions feature state-of-the-art talks in genome biology and genome sequencing for guiding medicine decisions, clinical trial designs and tailored medical treatments. This meeting offers a rare and unique opportunity to explore the most current breakthroughs in genetics and personalized medicine from within and outside the field of cardiovascular biology.
Scholarship Deadline: September 12 2012
Discounted Abstract Deadline: September 12 2012
Abstract Deadline: October 25 2012
Discounted Registration Deadline: November 12 2012
We gratefully acknowledge additional support for this conference from:
American Heart Association's Council on Functional Genomics and Translational Biology
$2,500 - $9,999
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL115913-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.